Skip to main content

Peer Review reports

From: Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map

Original Submission
2 Feb 2022 Submitted Original manuscript
22 Jun 2022 Author responded Author comments - Julia Colombijn
Resubmission - Version 2
22 Jun 2022 Submitted Manuscript version 2
8 Jul 2022 Author responded Author comments - Julia Colombijn
Resubmission - Version 3
8 Jul 2022 Submitted Manuscript version 3
20 Jul 2022 Author responded Author comments - Julia Colombijn
Resubmission - Version 4
20 Jul 2022 Submitted Manuscript version 4
21 Jul 2022 Author responded Author comments - Julia Colombijn
Resubmission - Version 5
21 Jul 2022 Submitted Manuscript version 5
1 Aug 2022 Reviewed Reviewer Report - Dorota Formanowicz
13 Aug 2022 Reviewed Reviewer Report - Yeshwanter Radhakrishnan
14 Aug 2022 Reviewed Reviewer Report - Wisit Kaewput
19 Aug 2022 Reviewed Reviewer Report - Annop Kittithaworn
20 Sep 2022 Author responded Author comments - Julia Colombijn
Resubmission - Version 6
20 Sep 2022 Submitted Manuscript version 6
4 Oct 2022 Reviewed Reviewer Report - Yeshwanter Radhakrishnan
11 Oct 2022 Reviewed Reviewer Report - Dorota Formanowicz
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
25 Oct 2022 Editorially accepted
12 Nov 2022 Article published 10.1186/s13643-022-02108-x

You can find further information about peer review here.

Back to article page